Here, we reveal that the m6A methyltransferase complex METTL3/METTL14 is upregulated in CML patients and that is required for proliferation of primary CML cells and CML cell lines sensitive and resistant to the TKI imatinib. The gene discussed is METTL14; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.